- Home
- ARMP vs USGO Comparison
ARMP vs USGO Comparison
Compare ARMP & USGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | USGO |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.7M | 147.8M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | ARMP | USGO |
|---|---|---|
| Price | $7.35 | $9.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $9.00 | ★ $26.50 |
| AVG Volume (30 Days) | ★ 99.2K | 48.7K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,054,000.00 | N/A |
| Revenue This Year | $8.43 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.90 | $7.26 |
| 52 Week High | $16.34 | $14.93 |
Technical Indicators
Market Signals| Indicator | ARMP | USGO |
|---|---|---|
| Relative Strength Index (RSI) | 65.33 | 43.31 |
| Support Level | $6.81 | $8.82 |
| Resistance Level | $7.40 | $10.02 |
| Average True Range (ATR) | 0.67 | 0.57 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 89.99 | 41.81 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About USGO U.S. GoldMining Inc. Common stock
US Goldmining Inc is a mineral exploration and development company. It is focused on the exploration and development of a project located in Alaska, USA. The company's sole property is Whistler Project which is a gold-copper exploration project located in the Yentna Mining District, approximately 170 km northwest of Anchorage, Alaska.